Benefit Corporation: a path to affordable gene therapies?

Author: Alain Fischer, Mathias Dewatripont, Michel Goldman

Categories: Article, English, Research, Restricted access

Tags: Benefit Corporation, Critiques

The following content is accessible for members only, please sign in.

Upcoming Events

• B Impact Teams Quarterly Office Hours
• 2025 B Academics All Members Meeting
• Q1 2025 B Academics Research Committee Meeting
• B Impact Teams Quarterly Office Hours
• B Impact Teams Quarterly Office Hours
• B Impact Teams Quarterly Office Hours

Past Event

• Global Event 2024: LATAM
• Q4 B Academics Research Committee Meeting
• B Impact Teams Webinar
• B Impact Teams Conversation Series
• B Academics Teaching Roundtable 2024
• Chat with the Board Series: The Evolution of the Standards

Support B Academics

Our organization is able to continue its mission because of your support and generosity.
By contributing to B Academics, you’ll help ensure that our work continues.